122 related articles for article (PubMed ID: 29129656)
1. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.
Péraudeau E; Cronier L; Monvoisin A; Poinot P; Mergault C; Guilhot F; Tranoy-Opalinski I; Renoux B; Papot S; Clarhaut J
J Control Release; 2018 Jan; 269():36-44. PubMed ID: 29129656
[TBL] [Abstract][Full Text] [Related]
2. Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone.
Chen H; Zhang T; Zhou Z; Guan M; Wang J; Liu L; Zhang Q
Int J Pharm; 2013 May; 448(1):142-9. PubMed ID: 23538095
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
[TBL] [Abstract][Full Text] [Related]
4. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
6. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.
Vaitilingam B; Chelvam V; Kularatne SA; Poh S; Ayala-Lopez W; Low PS
J Nucl Med; 2012 Jul; 53(7):1127-34. PubMed ID: 22693311
[TBL] [Abstract][Full Text] [Related]
7. Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Chu H; Shillingford JM; Reddy JA; Westrick E; Nelson M; Wang EZ; Parker N; Felten AE; Vaughn JF; Xu LC; Lu YJ; Vlahov IR; Leamon CP
Mol Pharm; 2019 Sep; 16(9):3985-3995. PubMed ID: 31356752
[TBL] [Abstract][Full Text] [Related]
8. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
9. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting.
Tran T; Shatnawi A; Zheng X; Kelley KM; Ratnam M
Cancer Res; 2005 May; 65(10):4431-41. PubMed ID: 15899836
[TBL] [Abstract][Full Text] [Related]
11. The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth
Tran LNK; Kichenadasse G; Morel KL; Lavranos TC; Klebe S; Lower KM; Ormsby RJ; Elliot DJ; Sykes PJ
In Vivo; 2019; 33(1):99-108. PubMed ID: 30587609
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD-Peptide-Functionalized Polylipopeptide Micelles for Enhanced Loading and Targeted Delivery of Monomethyl Auristatin E.
Qiu M; Wang X; Sun H; Zhang J; Deng C; Zhong Z
Mol Pharm; 2018 Nov; 15(11):4854-4861. PubMed ID: 30259747
[TBL] [Abstract][Full Text] [Related]
13. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
14. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
Serwotka-Suszczak AM; Sochaj-Gregorczyk AM; Pieczykolan J; Krowarsch D; Jelen F; Otlewski J
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216573
[TBL] [Abstract][Full Text] [Related]
15. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
Ledermann JA; Canevari S; Thigpen T
Ann Oncol; 2015 Oct; 26(10):2034-43. PubMed ID: 26063635
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor Alpha-A Novel Approach to Cancer Therapy.
Gonzalez T; Muminovic M; Nano O; Vulfovich M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256120
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Burns KE; Robinson MK; Thévenin D
Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional folate receptors in multiple myeloma.
Zhou Y; Unno K; Hyjek E; Liu H; Zimmerman T; Karmakar S; Putt KS; Shen J; Low PS; Wickrema A
Leuk Lymphoma; 2018 Dec; 59(12):2982-2989. PubMed ID: 29616859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
